Micro Cap
Medical Distribution
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
EDAP TMS S.A.
FOCL
$193M
| $193M | $4.09 | 0.97% |
|
| 2 |
2
Cosmos Holdings
COSM
$33.3M
| $33.3M | $0.3313 | 1.52% |
|
| 3 |
3
111 Inc
YI
$27.5M
| $27.5M | $3.13 | 1.29% |
|
| 4 |
4
Accendra Health
ACH
$18.1M
| $18.1M | $0.2350 | 10.1% |
|
| 5 |
5
DataMeds AI
MEDS
$8.41M
| $8.41M | $2.63 | 7.72% |
|
| 6 |
6
Cellyan Biotechnology
HKPD
$5.43M
| $5.43M | $0.1102 | 0.27% |
|
Micro Cap Medical Distribution Stocks at a Glance
Medical distributors supply drugs, instruments, and healthcare products to pharmacies, hospitals, and clinics. Pennies of margin on huge volumes make scale and logistics efficiency decisive, with steady demand offset by drug-pricing and contract-renewal pressure.
There are 6 micro cap Medical Distribution stocks — companies in the Medical Distribution industry with a market cap under $250M — worth a combined $286M.
The largest by market cap are EDAP TMS S.A. (FOCL) at $193M, Cosmos Holdings (COSM) at $33.3M and 111 Inc (YI) at $27.5M.
Among institutional investors, Cellyan Biotechnology (HKPD) drew the most net new fund positions in Q2 2026: 3 funds opened new positions, taking total fund holders up 2 (50%) quarter-over-quarter.
- Combined market cap: $286M across 6 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: EDAP TMS S.A. (FOCL), $193M market cap.
- Most net new fund positions in Q2 2026: Cellyan Biotechnology (HKPD), +2 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.